Based on Turnaround Radar's research: "The P&L and the Product"

The Verdict: ⛔ AVOID (MED conviction)

Newell Brands is statistically cheap — 0.21x P/S, ~6x forward earnings — but cheapness without a functioning moat is the textbook definition of a value trap. The council's moat erosion finding, backed by uniformly negative consumer quality signals across every major brand and nine consecutive years of revenue decline, is the governing constraint that overrides the favorable valuation.

How the Council Voted

🛡 Moat Auditor — ERODING

The consumer-facing evidence is uniformly negative across Newell's largest brands. Yankee Candle carries a 1.3/5 rating on Sitejabber with a 75% one-star share — an extreme statistical outlier even on complaint-skewed platforms, driven by recurring scent-throw and tunneling complaints that describe a product formula that has changed, not a customer base that has become pickier. Rubbermaid holds 2.1/5 on PissedConsumer with premature lid breakage and poor warranty fulfillment as the dominant complaint categories. Crock-Pot faces an active class action alleging nonstick coating that bubbles, flakes, and peels into food. FoodSaver sits at 2.3/5. The weighted portfolio average is approximately 1.8/5 — every brand reviewed sits below industry norms for its category.

The financial picture tells a different story, but that's the problem. Gross margin expanded to 33.1% in Q1 2026, the eighth consecutive quarter of 100bps+ improvement. Management is delivering real cost savings through the Global Productivity Plan, 900 layoffs, and procurement optimization. But the margin expansion is coming from cost engineering, not from pricing power or product premiumization. At ~33%, Newell trails Energizer (~41%) and Church & Dwight (~45%) — peers in the same broad category — by 800-1,200 basis points. This is not a company that can charge a premium.

Revenue tells the moat story most clearly. The Mann-Kendall trend test on 2017-2025 annual revenue yields tau = -0.611, p = 0.025 — a statistically significant downward trend spanning nine consecutive years from the $14.7B post-Jarden peak to $7.27B. Q1 2026 showed deceleration of the decline to -1.1%, approaching flat, but not yet crossing the line. No direct customer retention data is available because Newell's brands sell through third-party retailers, creating a structural blind spot in the moat assessment.

🔍 Crisis Diagnostician — REAL_BUT_FIXABLE

The crisis is real. Revenue has declined for nine years. Leverage sits at 7.1x debt/EBITDA with $5.0B in total debt against a $1.44B market cap. Free cash flow collapsed to $17M in FY2025 after $247M in capex consumed most of the $264M operating cash flow. Moody's downgraded to B2; S&P to B+. The $1.24B 2028 notes were refinanced from 4.2% to 8.5% — the coupon more than doubled, diverting cash from brand reinvestment to debt service. The market fear that this is a leveraged value trap with deteriorating brands is largely justified by the data.

But the crisis is bounded. The Q1 2026 beat — revenue $1.55B versus $1.51B consensus, guidance raised to flat-to-+2% net sales — suggests revenue deceleration is real, not manufactured. The most immediate maturity (the 2026 notes) has been refinanced. China sourcing is below 10%, down from 30%+, giving Newell a genuine tariff-advantaged position relative to peers. The Global Productivity Plan targets $110-130M in annualized savings. The path to fix is visible; it requires revenue stabilization that has not yet been achieved.

The doom-loop risk is moderate. A feedback loop exists: cost cuts degrade product quality, which degrades brands, which degrades revenue, which increases leverage, which increases borrowing costs. Peterson's innovation investment and tariff positioning are potential circuit breakers, but the window to break this loop is 4-6 quarters. Q2 2026 earnings on July 31 is the decider.

💪 Capability Assessor — ADEQUATE

Chris Peterson is running a coherent, specific turnaround plan. He came from 20 years at Procter & Gamble and served as Newell's CFO before taking the CEO role in May 2023. The plan has named initiatives (Project Ovid, Global Productivity Plan, Quantum Leap AI program), quantified targets (25 innovation launches, <10% China sourcing, $75-90M annual savings), and a milestone calendar. This is well above the vagueness threshold that signals performative management. CFO Mark Erceg brings a strong pedigree — Tiffany & Co. through the LVMH acquisition, Canadian Pacific Railway — and has managed the near-term maturity wall without equity dilution.

Early execution is encouraging. Yankee Candle's relaunch delivered 6% core sales growth in Q4 2025 — the first proof that the innovation pipeline can move a specific brand. Q1 2026 was the first clean beat-and-raise cycle since the crisis intensified. Revenue decline decelerated from -7.3% to -1.1%. But Peterson has no prior completed turnaround on his resume — his Revlon tenure as COO/CFO ended four years before Revlon's Chapter 11.

The insider selling is the most damaging data point. In May 2026, three C-suite officers sold aggressively: CHRO Tracy Platt liquidated 100% of her direct equity holdings, CLO Bradford Turner sold 100,000 shares, and EVP Melanie Huet sold 91,000 shares. No open-market insider purchases were identified. When executives sell 100% of holdings during a declared turnaround, the credibility gap between what management says and what management does with their own money is material.

💰 Valuation Analyst — CHEAP

On multiples alone, NWL is unambiguously cheap. P/S of 0.21x sits at the bottom decile of the 5-year range (median: 0.60x). Forward P/E of ~6x on normalized $0.57 EPS is 50-65% below peer medians. PEG of 0.97 signals the stock is cheap relative to its forward growth trajectory. The probability-weighted target from TR's scenario analysis is $4.15, putting the $3.41 current price 17.8% below the weighted midpoint.

Peer comparison reinforces the signal. Spectrum Brands trades at 13.3x EV/EBITDA, Energizer at 7.55x, Edgewell at 12.37x — the peer median of ~12.4x sits well above NWL's normalized ~9-10x (after adjusting for $340M in impairment charges that distort the TTM figure to a misleading 20.37x).

But the insider selling pattern partially offsets the cheapness signal. Three executives sold shares in May 2026 alone; zero open-market purchases were found since the 52-week high. When insiders themselves do not believe the equity is undervalued, the cheap multiple is informational — the market may be correct that this franchise does not warrant a higher valuation.

🏛 Chair (Synthesizer)

The primary tension is between the Valuation Analyst (CHEAP) and the Moat Auditor (ERODING). Cheap multiples on an eroding franchise are not a mispricing — they are the market correctly discounting a deteriorating asset. The decision matrix exists precisely for cases like this. The Valuation Analyst's own report flags insider selling as the one contradictory signal within the cheapness thesis; the Capability Assessor confirms that management itself is not voting with their wallets.

A secondary tension exists between the Crisis Diagnostician (REAL_BUT_FIXABLE) and the Moat Auditor (ERODING). The Crisis Diagnostician identifies a plausible near-term path to stabilization — Q1 beat, margin trajectory, tariff positioning. This is a fair reading of the operational picture. But the moat verdict reflects a longer-arc assessment: the brand franchise has been in continuous decline since 2017, consumer quality signals are uniformly negative, and margin improvement at the expense of product investment is a pattern that eventually breaks. Even if Peterson stabilizes the P&L, there is no evidence the brands themselves are recovering.

The moat governs. All four specialists reported at MED confidence, creating an internally consistent but data-limited picture. Conviction is MEDIUM — we are confident in the direction (AVOID) but acknowledge that the thin consumer-voice samples and missing retention data leave room for the picture to shift.

What Would Change Our Verdict

  • Two consecutive quarters of positive core sales growth (Q2 and Q3 2026) combined with consumer review scores inflecting upward — Yankee Candle crossing 2.0/5, new launches earning 3.5+ on Amazon — would challenge the ERODING moat verdict and potentially flip the matrix to BUY or STRONG_BUY given the cheap valuation.

  • Meaningful open-market insider purchases totaling $500K+ by Peterson or Erceg would directly contradict the bearish selling pattern and signal genuine conviction in the equity.

  • 2027 refinancing at sub-7% would signal credit-market confidence in the turnaround and relieve the interest-expense pressure diverting cash from brand investment.

  • Revenue decline reaccelerating to -3% or worse in Q2 would confirm that the ERODING verdict understates the problem and would likely trigger a downgrade toward DAMAGED.

What to Watch

  • Q2 FY26 earnings (July 31, 2026): Core sales positive or negative — the single most important near-term data point. The decider quarter.

  • Insider Form 4 filings (ongoing): Any open-market purchases by Peterson, Erceg, or board members. Continued selling reinforces AVOID.

  • Consumer review trajectories: Yankee Candle Sitejabber score, Crock-Pot class action resolution, Amazon ratings on 2026 innovation launches — leading indicators of whether cost-engineered margins are offset by brand decay.

  • 2027 refinancing terms (Q3-Q4 2026): The coupon on the $495-500M September 2027 maturity will be the credit market's verdict on the turnaround. Above 9% signals distress.

  • Tariff developments: Newell's sub-10% China sourcing is a competitive advantage, but escalation to 125%+ tariffs on remaining categories or new Mexico tariffs could overwhelm the organic trajectory.

This analysis is research, not investment advice. The TR research it's built on is at turnaroundradar.com. For all current verdicts across the portfolio, see The Verdict Board.

Keep reading